Rocket


News + Filings
Transactions





Nagler David

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
06/20/2018Audentes Therapeutics, Inc.BOLDExerciseStock Option (right to buy)5k$2.19$10.9k 06/20/2018
06/20/2018Audentes Therapeutics, Inc.BOLDSaleCommon Stock300$46.02$13.8k 06/20/2018
06/20/2018Audentes Therapeutics, Inc.BOLDSaleCommon Stock4.7k$45.25$212.7k 06/20/2018
11/16/2017Audentes Therapeutics, Inc.BOLDGrantStock Option (right to buy)50k$27.39$1.4M 11/16/2017
09/27/2017Audentes Therapeutics, Inc.BOLDExerciseStock Option (right to buy)3.8k$2.19$8.2k 09/27/2017
09/27/2017Audentes Therapeutics, Inc.BOLDSaleCommon Stock3.8k$30.00$112.5k 09/27/2017
09/15/2017Audentes Therapeutics, Inc.BOLDExerciseStock Option (right to buy)3.8k$2.19$8.2k 09/15/2017
09/15/2017Audentes Therapeutics, Inc.BOLDSaleCommon Stock3.8k$25.00$93.8k 09/15/2017
01/25/2017Audentes Therapeutics, Inc.BOLDGrantStock Option (right to buy)50k$15.26$763k 01/25/2017
02/25/2010ARYx Therapeutics, Inc.ARYXGrantRestricted Stock Units130k$0.00$0 02/25/2010

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy